| Volume 19, 2015 Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
PreScription: 2014 in Review
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 4
|
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jan/Feb 2015
Pg. 6-12
|
Giving Back: A Win-Win Plan of Action for Compounding Pharmacists
Rudner Shara
|
Jan/Feb 2015
Pg. 14-17
|
Pharmacy Student Survey: Perceptions and Expectations of Pharmaceutical Compounding
Carvalho Maria, Batra Bindhu
|
Jan/Feb 2015
Pg. 18-27
|
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance
Grilli Anthony, Sutton Scott
|
Jan/Feb 2015
Pg. 30-37
|
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 38-40
|
Quality Control Analytical Methods: Refractive Index
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 43-47
|
Basics of Sterile Compounding: Aseptic Processing
Akers Michael J
|
Jan/Feb 2015
Pg. 49-56
|
Basics of Compounding: The Revised "Not to Compound List"
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 57-58
|
Calculations
Stockton Shelly J
|
Jan/Feb 2015
Pg. 59
|
Atenolol 25-, 50-, or 100-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 60
|
Azathioprine 50-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 61
|
Cisplatin 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 62
|
Daunorubicin 5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 63
|
Erythromycin 50-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 64
|
Hydralazine Hydrochloride 20-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 65
|
Hydroxychloroquine Sulfate 200-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 66
|
Lidocaine Hydrochloride 4% Topical Solution
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 67
|
Mupirocin 2% Ointment
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 68
|
Phentolamine Mesylate 5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 69
|
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration
Pereboom Marieke, Becker Matthijs L, Amenchar Mostapha, Verweij Sjoerd L, van der Hoeven Ruud TM, Mulder Inge J
|
Jan/Feb 2015
Pg. 70-72
|
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions
Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica
|
Jan/Feb 2015
Pg. 73-77
|
Stability of Suspensions: Theoretical and Practical Considerations before Compounding
Hadziabdic Jasmina, Elezovic Alisa, Rahic Ognjenka, Mujezin Indira, Vranic Edina
|
Jan/Feb 2015
Pg. 78-85
|
PostScription: Pharmacists Advancing Toward Provider Status
Menighan Thomas E
|
Jan/Feb 2015
Pg. 86-87
|
PreScription: Some of the Best Sermons are Lived, not Preached!
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 92
|
New England Compounding Center Indictment
Cabaleiro Joe
|
Mar/Apr 2015
Pg. 94-102
|
Standing Together Fixing the Drug Quality and Security Act
Miller David G
|
Mar/Apr 2015
Pg. 104-106
|
Standarized Compounding: The Importance of Doing it the Same Way Every Time
Dillon L Rad
|
Mar/Apr 2015
Pg. 109-112
|
Bedside Manner: Not Just for Doctors Anymore
Cormier Mindy
|
Mar/Apr 2015
Pg. 115-118
|
Quality Assurance and Quality Control, Part 1
Akers Michael J
|
Mar/Apr 2015
Pg. 121-124
|
Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing
Akers Michael J
|
Mar/Apr 2015
Pg. 127-138
|
Calculations
Stockton Shelly J
|
Mar/Apr 2015
Pg. 140-141
|
Acne Scrub
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 142
|
Aminohippurate Sodium 200-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 143
|
Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 144
|
Heparin 335-United/Gram Gel-Cream
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 145
|
L-Cysteine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 146
|
Morrhuate Sodium 5% Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 147
|
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 148
|
Pancuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 149
|
Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 150
|
Trypan Blue 0.06% Ophthalmic Solution
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 151
|
Transdermal Delivery of Nisoldipine: Refinement of Vehicles
El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
|
Mar/Apr 2015
Pg. 152-160
|
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
|
Mar/Apr 2015
Pg. 161-166
|
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time
Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
|
Mar/Apr 2015
Pg. 167-173
|
PostScription: What's Your Patient Care Story?
Menighan Thomas E
|
Mar/Apr 2015
Pg. 174-175
|
PreScription: 2015 Student Pharmacist Compounding Competition
Allen Loyd V Jr
|
May/Jun 2015
Pg. 180
|
Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities
Weller Tom, Kragseth Rolf, Dullinger Roger, Illum Henrik, Perry Alan
|
May/Jun 2015
Pg. 182-192
|
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Guth Michael AS
|
May/Jun 2015
Pg. 195-203
|
Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls
Gonzalez Mark
|
May/Jun 2015
Pg. 205-211
|
IACP Says: "Fix DQSA"
Miller David
|
May/Jun 2015
Pg. 212
|
Quality Assurance and Quality Control, Part 2
Akers Michael J
|
May/Jun 2015
Pg. 215-221
|
Basics of Compounding: Compounding with Silicones
Allen Loyd V Jr
|
May/Jun 2015
Pg. 223-230
|
Basics of Sterile Compounding: Contamination Control
Akers Michael J
|
May/Jun 2015
Pg. 232-238
|
Calculations
Stockton Shelly J, Saluja Hardeep Singh
|
May/Jun 2015
Pg. 240-241
|
Atropine Sulfate 1% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2015
Pg. 242
|
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
|
May/Jun 2015
Pg. 243
|
Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches
Allen Loyd V Jr
|
May/Jun 2015
Pg. 244
|
Phenazopyridine Hydrochloride 200-mg Capsules
Allen Loyd V Jr
|
May/Jun 2015
Pg. 245
|
Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2015
Pg. 246
|
Scopolamine Hydrobromide -.4-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2015
Pg. 247
|
Stability of Metronidazole Suspensions
Donnelly Ronald F, Ying James
|
May/Jun 2015
Pg. 248-251
|
Protocol of Blood Serum Eye Drops
Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
|
May/Jun 2015
Pg. 252-260
|
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials
Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
|
May/Jun 2015
Pg. 261-267
|
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles
Dewulf Joseph, Hecq Jean-Daniel, Huvelle Sophie, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
May/Jun 2015
Pg. 268-270
|
PostScription: Opportunities to Change the Pharmacy Landscape
Menighan Thomas E
|
May/Jun 2015
Pg. 271
|
PreScription: Potpourri of Opinions…From Many
Allen Loyd V
|
Jul/Aug 2015
Pg. 266
|
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom
Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
|
Jul/Aug 2015
Pg. 268-278
|
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2
Allen Loyd V
|
Jul/Aug 2015
Pg. 280-287
|
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Biundo Bruce, Gogola Margaret
|
Jul/Aug 2015
Pg. 289-293
|
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jul/Aug 2015
Pg. 295-300
|
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
|
Jul/Aug 2015
Pg. 303-305
|
Quality Control Analytical Methods: Physical Quantitative Verification of Nonsterile Compounded Preparations: Individualized Dosage Units
Sidhu Raman
|
Jul/Aug 2015
Pg. 307-310
|
Basics of Compounding: The "Negative" List
Allen Loyd V
|
Jul/Aug 2015
Pg. 311-313
|
Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing
Akers Michael J
|
Jul/Aug 2015
Pg. 315-320
|
Calculations
Stockton Shelly J
|
Jul/Aug 2015
Pg. 322
|
Ammonium Molybdate 25-mcg/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 324
|
Balsam Peru, Castor Oil, and Trypsin Ointment
Allen Loyd V
|
Jul/Aug 2015
Pg. 325
|
Benzonatate 100-mg Capsules
Allen Loyd V
|
Jul/Aug 2015
Pg. 326
|
Chloroquine Phosphate 250-mg Capsules
Allen Loyd V
|
Jul/Aug 2015
Pg. 327
|
Cytarabine 50-mg/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 328
|
Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 329
|
Oxytocin 10-units/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 330
|
Phytonadione 2-mg/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 331
|
Proparacaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V
|
Jul/Aug 2015
Pg. 332
|
Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg
Allen Loyd V
|
Jul/Aug 2015
Pg. 333
|
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters
Puertos Enrique, Spencer Melissa
|
Jul/Aug 2015
Pg. 334-336
|
Stability of Prednisone in Oral Mix Suspending Vehicle
Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim
|
Jul/Aug 2015
Pg. 337-339
|
Development and Validation of an Inexpensive, Simple, and Rapid Technique for Measuring the Accuracy of Extemporaneously Compounded Pharmaceuticals
Meek Claudia, Rothardt Andrew, Evans Jason, Thurman Rosanne, Ashworth Lisa, Leff Richard
|
Jul/Aug 2015
Pg. 340-343
|
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes
Anderson Collin R, Halford Zachery, MacKay Mark
|
Jul/Aug 2015
Pg. 344-347
|
PostScription: APhA2015: You Spoke, We Listened, and What a Success!
Menighan Thomas E
|
Jul/Aug 2015
Pg. 348-349
|
PreScription: Failure or Success?
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 354
|
Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
|
Sep/Oct 2015
Pg. 357-365
|
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries
Guth Michael AS
|
Sep/Oct 2015
Pg. 367-373
|
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding
Miller David G
|
Sep/Oct 2015
Pg. 375
|
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
|
Sep/Oct 2015
Pg. 377-380
|
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations
Donnelly Ronald F
|
Sep/Oct 2015
Pg. 383-386
|
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 389-390
|
Sterile Filtration
Akers Michael J
|
Sep/Oct 2015
Pg. 393-401
|
Calculations
Stockton Shelly J, Saluja Hardeep Singh
|
Sep/Oct 2015
Pg. 402
|
Aminocaproic Acid 250-mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 404
|
Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 405
|
Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 406
|
Nimodipine 3-mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 407
|
Ofloxacin 0.3% Otic Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 408
|
Povidone Iodine 10% Cold Sore Paint
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 409
|
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 410
|
Vehicle for Oral Solution (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 411
|
Vehicle for Oral Solution, Sugar Free (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 412
|
Vehicle for Oral Suspension (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 413
|
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
|
Sep/Oct 2015
Pg. 414-419
|
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Geiger Christine M, Sorenson Bridget, Whaley Paul
|
Sep/Oct 2015
Pg. 420-427
|
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures
Nahata Milap C
|
Sep/Oct 2015
Pg. 428-431
|
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers
Bhattacharya Sisir, Parekh Satish, Dedhiya Mahendra
|
Sep/Oct 2015
Pg. 432-436
|
PostScription: Progress Report: Provider Status Continues to Gain Strength!
Menighan Thomas E
|
Sep/Oct 2015
Pg. 437
|
PreScription: The Documented Past and the Exciting Future
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 442
|
Clinical Perspectives in Compounding: Compounding Gains and Losses Since I Met "Careless Arithmetic Nullifies Careful Compounding"
Newton David W
|
Nov/Dec 2015
Pg. 444-446
|
International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance
Miller David G
|
Nov/Dec 2015
Pg. 449-450
|
Applying Quality of Design Concepts to Pharmacy Compounding
Timko Robert J
|
Nov/Dec 2015
Pg. 453-463
|
Root Cause Analysis, Part 1: Nonsterile Compounding
Cabaleiro Joe, Jackson Kathleen
|
Nov/Dec 2015
Pg. 465-469
|
Basic Principles of Lyophilization, Part 1
Akers Michael J
|
Nov/Dec 2015
Pg. 471-476
|
Mixing in a Compounding Pharmacy in the 21st Century
Standridge Rob
|
Nov/Dec 2015
Pg. 479-484
|
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 487-488
|
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Akers Michael J
|
Nov/Dec 2015
Pg. 491-500
|
Calculations
Stockton Shelly J
|
Nov/Dec 2015
Pg. 502
|
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 504
|
Cefepime Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 505
|
Cefotaxime 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 506
|
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 507
|
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 508
|
Estradiol Valerate 40-mg/mL in Oil Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 509
|
Levetiracetam 100-mg/mL Injection (Concentrate)
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 510
|
Memantine Hydrochloride Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 511
|
Mupirocin 2% Nasal Ointment
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 512
|
Propranolol Hydrochloride Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 513
|
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States
Lobb William B, Wilkin Noel E, Holmes Erin R
|
Nov/Dec 2015
Pg. 514-520
|
Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment
Hecq Jean-Daniel, Rolin Catherine, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
Nov/Dec 2015
Pg. 521-524
|
PostScription: Pharmacy Fellowship Program: Building a Stronger Profession
Bernardi Steve
|
Nov/Dec 2015
Pg. 525
|
| Return to Top |
